INMD

InMode Ltd.

Healthcare · $816M market cap

Verdict

Share price

$14.09

close of Oct 3, 2026

Fair value

$11.32

Sticker Price

Payback Price

$4.53

buy price

Overpriced

INMD is Overpriced: at $14.09 it trades 24% above its fair value of $11.32. Its buy price (Payback Price) is $4.53, 68% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow Growth. Free cash flow is growing faster than reported earnings, so we project free cash flow 10 years ahead instead.

Business quality

4 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth7.0% a year✗
Equity per share growth24.6% a year✓
Sales growth32.4% a year✓
Free cash flow growth29.1% a year✓
Return on invested capital16.1%✓

Follow INMD

Get notified when it reaches its buy price of $4.53. Free.

Create a free account

Superinvestors

1 of the investors we track holds INMD. In Q2 2026, 1 trimmed. Who we track

Moves in Q2 2026

Trimmed: Sarah Ketterer

Insider activity

Since Jul 30, 2026: no open-market purchases and 4 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

About InMode Ltd.

InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works